These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 20157737
1. DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome. Zipfel PF, Mache C, Müller D, Licht C, Wigger M, Skerka C, European DEAP-HUS Study Group. Pediatr Nephrol; 2010 Oct; 25(10):2009-19. PubMed ID: 20157737 [Abstract] [Full Text] [Related]
3. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Józsi M, Licht C, Strobel S, Zipfel SL, Richter H, Heinen S, Zipfel PF, Skerka C. Blood; 2008 Feb 01; 111(3):1512-4. PubMed ID: 18006700 [Abstract] [Full Text] [Related]
4. Atypical hemolytic uremic syndrome due to factor H autoantibody. Uslu-Gökceoğlu A, Doğan CS, Comak E, Koyun M, Akman S. Turk J Pediatr; 2013 Feb 01; 55(1):86-9. PubMed ID: 23692839 [Abstract] [Full Text] [Related]
5. Successful treatment of DEAP-HUS with eculizumab. Noone D, Waters A, Pluthero FG, Geary DF, Kirschfink M, Zipfel PF, Licht C. Pediatr Nephrol; 2014 May 01; 29(5):841-51. PubMed ID: 24249282 [Abstract] [Full Text] [Related]
6. Autoantibodies in haemolytic uraemic syndrome (HUS). Skerka C, Józsi M, Zipfel PF, Dragon-Durey MA, Fremeaux-Bacchi V. Thromb Haemost; 2009 Feb 01; 101(2):227-32. PubMed ID: 19190803 [Abstract] [Full Text] [Related]
7. Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS. Hackl A, Ehren R, Kirschfink M, Zipfel PF, Beck BB, Weber LT, Habbig S. Pediatr Nephrol; 2017 Jun 01; 32(6):1081-1087. PubMed ID: 28220235 [Abstract] [Full Text] [Related]
8. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency. Lee BH, Kwak SH, Shin JI, Lee SH, Choi HJ, Kang HG, Ha IS, Lee JS, Dragon-Durey MA, Choi Y, Cheong HI. Pediatr Res; 2009 Sep 01; 66(3):336-40. PubMed ID: 19531976 [Abstract] [Full Text] [Related]
9. The clinical spectrum of hemolytic uremic syndrome secondary to complement factor H autoantibodies. Kim JJ, McCulloch M, Marks SD, Waters A, Noone D. Clin Nephrol; 2015 Jan 01; 83(1):49-56. PubMed ID: 24131678 [Abstract] [Full Text] [Related]
10. Complement factor H related proteins in immune diseases. Skerka C, Zipfel PF. Vaccine; 2008 Dec 30; 26 Suppl 8():I9-14. PubMed ID: 19388158 [Abstract] [Full Text] [Related]
11. Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS. Dragon-Durey MA, Blanc C, Garnier A, Hofer J, Sethi SK, Zimmerhackl LB. Semin Thromb Hemost; 2010 Sep 30; 36(6):633-40. PubMed ID: 20865640 [Abstract] [Full Text] [Related]
12. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Abarrategui-Garrido C, Martínez-Barricarte R, López-Trascasa M, de Córdoba SR, Sánchez-Corral P. Blood; 2009 Nov 05; 114(19):4261-71. PubMed ID: 19745068 [Abstract] [Full Text] [Related]
13. Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T. Waters AM, Pappworth I, Marchbank K, Bockenhauer D, Tullus K, Pickering MC, Strain L, Sebire N, Shroff R, Marks SD, Goodship TH, Rees L. Am J Transplant; 2010 Jan 05; 10(1):168-72. PubMed ID: 19951285 [Abstract] [Full Text] [Related]
14. Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome. Strobel S, Abarrategui-Garrido C, Fariza-Requejo E, Seeberger H, Sánchez-Corral P, Józsi M. Kidney Int; 2011 Aug 05; 80(4):397-404. PubMed ID: 21677636 [Abstract] [Full Text] [Related]
15. Deficiency of CFHR plasma proteins and autoantibody positive hemolytic uremic syndrome: treatment rationale, outcomes, and monitoring. Iorember F, Nayak A. Pediatr Nephrol; 2021 Jun 05; 36(6):1365-1375. PubMed ID: 32529325 [Abstract] [Full Text] [Related]
16. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome. Hofer J, Janecke AR, Zimmerhackl LB, Riedl M, Rosales A, Giner T, Cortina G, Haindl CJ, Petzelberger B, Pawlik M, Jeller V, Vester U, Gadner B, van Husen M, Moritz ML, Würzner R, Jungraithmayr T, German-Austrian HUS Study Group. Clin J Am Soc Nephrol; 2013 Mar 05; 8(3):407-15. PubMed ID: 23243267 [Abstract] [Full Text] [Related]
17. The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome. Song D, Liu XR, Chen Z, Xiao HJ, Ding J, Sun SZ, Liu HY, Guo WY, Wang SX, Yu F, Zhao MH, Chinese Renal–TMA Network Institutes. Pediatr Nephrol; 2017 May 05; 32(5):811-822. PubMed ID: 28035470 [Abstract] [Full Text] [Related]
18. Deficiency of complement factor H-related proteins and autoantibody-positive hemolytic uremic syndrome in an infant with combined partial deficiencies and autoantibodies to complement factor H and ADAMTS13. Michael M, Turner N, Elenberg E, Shaffer LG, Teruya J, Arar M, Hui SK, Smith RJ, Moake J. Clin Kidney J; 2018 Dec 05; 11(6):791-796. PubMed ID: 30524124 [Abstract] [Full Text] [Related]
20. Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children. Sinha A, Gulati A, Saini S, Blanc C, Gupta A, Gurjar BS, Saini H, Kotresh ST, Ali U, Bhatia D, Ohri A, Kumar M, Agarwal I, Gulati S, Anand K, Vijayakumar M, Sinha R, Sethi S, Salmona M, George A, Bal V, Singh G, Dinda AK, Hari P, Rath S, Dragon-Durey MA, Bagga A, Indian HUS Registry. Kidney Int; 2014 May 05; 85(5):1151-60. PubMed ID: 24088957 [Abstract] [Full Text] [Related] Page: [Next] [New Search]